StockData
DiaMedica Therapeutics Inc. logo

DiaMedica Therapeutics Inc. (DMAC) stock

DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$8.38+0.05 (+0.60%)

Close on Nov 17, 2026Market cap $451.90MP/E –Yield –

DiaMedica Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

DiaMedica Therapeutics's price to sales ratio was 79.2× on Apr 30, 2019.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2019Apr 30, 201979.2×–

More DiaMedica Therapeutics figures

See a number that looks wrong?